155 related articles for article (PubMed ID: 33127459)
21. Treatment of hepatitis C virus recurrence after transplantation with sofosbuvir/ledipasvir: The role of ribavirin.
Globke B; Raschzok N; Teegen EM; Pratschke J; Schott E; Eurich D
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943544
[TBL] [Abstract][Full Text] [Related]
22. Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin.
Chen Y; Xu HX; Wang LJ; Liu XX; Mahato RI; Zhao YR
Aliment Pharmacol Ther; 2012 Jul; 36(2):91-103. PubMed ID: 22591106
[TBL] [Abstract][Full Text] [Related]
23. Impact of Interferon Lambda 4 Genotype on Interferon-Stimulated Gene Expression During Direct-Acting Antiviral Therapy for Hepatitis C.
Ramamurthy N; Marchi E; Ansari MA; Pedergnana V; Mclean A; Hudson E; ; Bowden R; Spencer CCA; Barnes E; Klenerman P
Hepatology; 2018 Sep; 68(3):859-871. PubMed ID: 29534310
[TBL] [Abstract][Full Text] [Related]
24. IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients.
El Awady MK; Bader El Din NG; Tabll A; El Hosary Y; Abdel Aziz AO; El Khayat H; Salama M; Abdelhafez TH
World J Gastroenterol; 2013 Jan; 19(2):290-8. PubMed ID: 23345953
[TBL] [Abstract][Full Text] [Related]
25. Test of IL28B polymorphisms in chronic hepatitis C patients treated with PegIFN and ribavirin depends on HCV genotypes: results from a meta-analysis.
Jia Z; Ding Y; Tian S; Niu J; Jiang J
PLoS One; 2012; 7(9):e45698. PubMed ID: 23029188
[TBL] [Abstract][Full Text] [Related]
26. Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia.
Tsertsvadze T; Gamkrelidze A; Nasrullah M; Sharvadze L; Morgan J; Shadaker S; Gvinjilia L; Butsashvili M; Metreveli D; Kerashvili V; Ezugbaia M; Chkhartishvili N; Abutidze A; Kvaratskhelia V; Averhoff F
BMC Infect Dis; 2020 Jan; 20(1):30. PubMed ID: 31924172
[TBL] [Abstract][Full Text] [Related]
27. Genetic variants in interferon-λ 4 influences HCV clearance in Chinese Han population.
Huang P; Yao Y; Yue M; Tian T; Chen H; Chen M; Wang J; Zhang Y; Yu R
Sci Rep; 2017 Feb; 7():42408. PubMed ID: 28186161
[TBL] [Abstract][Full Text] [Related]
28. Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-α-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.
Bhushan A; Ghosh S; Bhattacharjee S; Chinnaswamy S
J Interferon Cytokine Res; 2017 Aug; 37(8):369-382. PubMed ID: 28727946
[TBL] [Abstract][Full Text] [Related]
29. Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case-control study.
Grzegorzewska AE; Mostowska A; Warchoł W; Jagodziński PP
BMC Infect Dis; 2021 Aug; 21(1):875. PubMed ID: 34445971
[TBL] [Abstract][Full Text] [Related]
30. Demographics, clinical characteristics, IFNL3- and IFNL4- polymorphisms in a cohort of hepatitis C patients from Puerto Rico.
Morales-Vásquez L; Miranda-Avalo EI; Rodríguez-Medina JR; Quiñones-Badillo Y; Marqués-Lespier J; Muñoz-Acabá J; Pastrana R; Pérez-Cardona CM; Yamamura Y; Torres EA
P R Health Sci J; 2014 Dec; 33(4):177-83. PubMed ID: 25563035
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of
Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
[TBL] [Abstract][Full Text] [Related]
32. Sofosbuvir in the treatment of early HCV infection in HIV-infected men.
El Sayed A; Barbati ZR; Turner SS; Foster AL; Morey T; Dieterich DT; Fierer DS;
HIV Clin Trials; 2017 Mar; 18(2):60-66. PubMed ID: 28183221
[TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotypes 1-4 and 6 in Myanmar: Real-world experience.
Hlaing NKT; Mitrani RA; Aung ST; Phyo WW; Serper M; Kyaw AMM; Bwa AH; Win KM; Reddy KR
J Viral Hepat; 2017 Nov; 24(11):927-935. PubMed ID: 28475232
[TBL] [Abstract][Full Text] [Related]
34. Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels.
Jouvin-Marche E; Macek Jílková Z; Thelu MA; Marche H; Fugier E; Van Campenhout N; Hoang XS; Marlu A; Sturm N; Callanan M; Leroy V; Zarski JP; Marche PN
J Infect Dis; 2014 Jun; 209(12):1907-15. PubMed ID: 24415789
[TBL] [Abstract][Full Text] [Related]
35. Absence of interferon-λ 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection.
Waldenström J; Kåberg M; Alanko Blomé M; Widell A; Björkman P; Nilsson S; Hammarberg A; Weiland O; Nyström K; Lagging M
Scand J Gastroenterol; 2021 Jul; 56(7):855-861. PubMed ID: 34034600
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-28b CC genotype predicts early treatment response and CT/TT genotypes predicts non-response in patients infected with HCV genotype 3.
Gupta AC; Trehanpati N; Sukriti S; Hissar S; Midha V; Sood A; Sarin SK
J Med Virol; 2014 Apr; 86(4):707-12. PubMed ID: 24415442
[TBL] [Abstract][Full Text] [Related]
37. Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C.
Susser S; Herrmann E; Lange C; Hamdi N; Müller T; Berg T; Perner D; Zeuzem S; Sarrazin C
PLoS One; 2014; 9(11):e112592. PubMed ID: 25393304
[TBL] [Abstract][Full Text] [Related]
38. Association between variants in the interferon lambda 4 locus and substitutions in the hepatitis C virus non-structural protein 5A.
Akamatsu S; Hayes CN; Ochi H; Uchida T; Kan H; Murakami E; Abe H; Tsuge M; Miki D; Akiyama R; Hiraga N; Imamura M; Aikata H; Kawaoka T; Kawakami Y; Chayama K
J Hepatol; 2015 Sep; 63(3):554-63. PubMed ID: 25849245
[TBL] [Abstract][Full Text] [Related]
39. Core mutations, IL28B polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1 infection.
Alestig E; Arnholm B; Eilard A; Lagging M; Nilsson S; Norkrans G; Wahlberg T; Wejstål R; Westin J; Lindh M
BMC Infect Dis; 2011 May; 11():124. PubMed ID: 21569441
[TBL] [Abstract][Full Text] [Related]
40. Early viral kinetics during hepatitis C virus genotype 6 treatment according to IL28B polymorphisms.
Akkarathamrongsin S; Payungporn S; Thong VD; Poovorawan K; Prapunwattana P; Poovorawan Y; Tangkijvanich P
World J Gastroenterol; 2014 Aug; 20(30):10599-605. PubMed ID: 25132781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
